Activation of Leukotriene Synthesis in Human Neutrophils by Exogenous Arachidonic Acid: Inhibition by Adenosine A2aReceptor Agonists and Crucial Role of Autocrine Activation by Leukotriene B4
Cell Nucleus
Epoxide Hydrolases
0301 basic medicine
Leukotrienes
0303 health sciences
Adenosine
Arachidonate 5-Lipoxygenase
Arachidonic Acid
Indoles
Carboxylic Acids
Biological Transport
In Vitro Techniques
Adrenergic Agonists
Leukotriene B4
3. Good health
Autocrine Communication
Kinetics
03 medical and health sciences
Eicosapentaenoic Acid
Humans
Leukotriene Antagonists
Benzopyrans
Calcium
Biotransformation
DOI:
10.1124/mol.56.5.1055
Publication Date:
2018-01-08T20:37:23Z
AUTHORS (4)
ABSTRACT
We report here that the apparent inability of isolated human polymorphonuclear leukocytes (PMNs) to efficiently transform arachidonic acid (AA) is consequence A<sub>2a</sub> receptor engagement by endogenous adenosine accumulating in incubation media. Indeed, when eliminated from PMN suspensions addition deaminase, or cells are incubated with antagonists, important quantities (40–80 pmol/10<sup>6</sup> cells) 5-lipoxygenase products synthesized 1 5 μM exogenous AA. The selective agonist CGS21680 was a very potent inhibitor AA-induced leukotriene (LT) synthesis, showing an IC<sub>50</sub> ∼1 nM. mechanism stimulation LT synthesis observed absence extracellular investigated. In deaminase-treated PMN, AA induced Ca<sup>2+</sup> mobilization and translocation nuclear structures. A time lag 20 60 s (variable between preparations) consistently elevation intracellular concentration (and synthesis), indicating itself did not trigger PMN. This Ca<sup>2+</sup>mobilization, as well corresponding blocked MK0591, LTB<sub>4</sub> antagonists CP105696 LY223982, LTA<sub>4</sub> hydrolase SC57461A. These data demonstrate highly effective activator acts through requires autocrine stimulatory loop LTB<sub>4</sub>.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (41)
CITATIONS (62)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....